take lenzetto buyout amount out of revenue (one off item) and not much more increase than previous 12 months. BUT love the way the revenue growth is being "marketed" - aooears as if its from royalties - i guess buyout of lenzetto royalyties can be classified as such but should be imo shown as a separate item so as not to confuse that rely on reading financials.
anyhow i can not see much progression on pipeline activity and good to know that the commercialised products in the portfolio slide 4 are included in the approved column as well.
obviously trying to put sme distance between last and next CR's - anyhow heres hoping that sustained revenue growth can commence in the next 12 months as they may not be getting that one off royalty sell out payment again.
all imo
ACR Price at posting:
4.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)